Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025-2026.

McConeghy KW, Wilker EH, DeVone F, Skov B, Sun T, Patry E, Newbern EC, Araujo AB, Ghaswalla P, Clarke C, Tufts JR, Abul Y, Gravenstein S

Open source

DOI
10.1016/j.vaccine.2026.128882
Published
2026 Aug 13
Container
Vaccine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2026.128882,
  title = {Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025-2026.},
  author = {McConeghy KW and Wilker EH and DeVone F and Skov B and Sun T and Patry E and Newbern EC and Araujo AB and Ghaswalla P and Clarke C and Tufts JR and Abul Y and Gravenstein S},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2026.128882},
  url = {https://doi.org/10.1016/j.vaccine.2026.128882}
}

RIS

TY  - JOUR
TI  - Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025-2026.
AU  - McConeghy KW
AU  - Wilker EH
AU  - DeVone F
AU  - Skov B
AU  - Sun T
AU  - Patry E
AU  - Newbern EC
AU  - Araujo AB
AU  - Ghaswalla P
AU  - Clarke C
AU  - Tufts JR
AU  - Abul Y
AU  - Gravenstein S
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2026.128882
UR  - https://doi.org/10.1016/j.vaccine.2026.128882
ER  - 

APA

KW, M., EH, W., F, D., B, S., T, S., E, P., EC, N., AB, A., P, G., C, C., JR, T., Y, A., & S, G. (2026). Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025-2026.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128882

Source records